1887

Abstract

Non-structural protein NS1 of influenza A viruses interacts with cellular factors through its N-terminal RNA-binding, middle effector and C-terminal non-structured domains. NS1 attenuates antiviral responses in infected cells and thereby secures efficient virus replication. Some influenza strains express C-terminally truncated NS1 proteins due to nonsense mutations in the NS1 gene. To understand the role of the NS1 C-terminal region in regulation of antiviral responses, we engineered influenza viruses expressing C-terminally truncated NS1 proteins using A/WSN/33(H1N1) reverse genetics and tested them in human macrophages and in mice. We showed that a WSN virus expressing NS1 with a 28 aa deletion from its C terminus is a more powerful inducer of antiviral responses than the virus expressing full-length NS1, or one with a 10 aa truncation of NS1 in vitro. Thus, our findings suggest that the C-terminal region of NS1 is essential for regulation of antiviral responses. Moreover, viruses expressing truncated NS1 proteins could be good vaccine candidates.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000171
2015-08-01
2019-12-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/8/2086.html?itemId=/content/journal/jgv/10.1099/vir.0.000171&mimeType=html&fmt=ahah

References

  1. Ayllon J., García-Sastre A.. ( 2015;). The NS1 protein: a multitasking virulence factor. Curr Top Microbiol Immunol 386: 73–107 [PubMed].
    [Google Scholar]
  2. Denisova O.V., Kakkola L., Feng L., Stenman J., Nagaraj A., Lampe J., Yadav B., Aittokallio T., Kaukinen P.. ( 2012;). Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection. J Biol Chem 287: 35324–35332 [CrossRef] [PubMed].
    [Google Scholar]
  3. Denisova O.V., Söderholm S., Virtanen S., Von Schantz C., Bychkov D., Vashchinkina E., Desloovere J., Tynell J., Ikonen N.. ( 2014;). Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro. Antimicrob Agents Chemother 58: 3689–3696 [CrossRef] [PubMed].
    [Google Scholar]
  4. Dundon W.G., Capua I.. ( 2009;). A closer look at the NS1 of influenza virus. Viruses 1: 1057–1072 [CrossRef] [PubMed].
    [Google Scholar]
  5. Hale B.G., Randall R.E., Ortín J., Jackson D.. ( 2008;). The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359–2376 [CrossRef] [PubMed].
    [Google Scholar]
  6. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G.. ( 2000;). A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108–6113 [CrossRef] [PubMed].
    [Google Scholar]
  7. Jackson D., Hossain M.J., Hickman D., Perez D.R., Lamb R.A.. ( 2008;). A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105: 4381–4386 [CrossRef] [PubMed].
    [Google Scholar]
  8. Jalovaara P., Bychkov D., Ahtiainen L., Kallio-Kokko H., Valkonen M., Kantele A., Mattila P., Almusa H., Kallioniemi O., Kainov D.. ( 2014;). Genetic instability of influenza pH1N1 viruses. Genome Announc 2: e00841–14 [CrossRef] [PubMed].
    [Google Scholar]
  9. Kakkola L., Denisova O.V., Tynell J., Viiliäinen J., Ysenbaert T., Matos R.C., Nagaraj A., Ohman T., Kuivanen S.. ( 2013;). Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice. Cell Death Dis 4: e742 [CrossRef] [PubMed].
    [Google Scholar]
  10. Kong W., Liu L., Wang Y., He Q., Wu S., Qin Z., Wang J., Sun H., Sun Y.. ( 2015;). C-terminal elongation of NS1 of H9N2 influenza virus induces a high level of inflammatory cytokines and increases transmission. J Gen Virol 96: 259–268 [CrossRef] [PubMed].
    [Google Scholar]
  11. Lakspere T., Tynell J., Kaloinen M., Vanlede M., Parsons A., Ikonen N., Kallio-Kokko H., Kantele A., Mattila P.. ( 2014;). Full-genome sequences of influenza A(H1N1)pdm09 viruses isolated from Finnish patients from 2009 to 2013. Genome Announc 2: e01004–e01013 [CrossRef] [PubMed].
    [Google Scholar]
  12. Müller K.H., Kakkola L., Nagaraj A.S., Cheltsov A.V., Anastasina M., Kainov D.E.. ( 2012;). Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci 33: 89–99 [CrossRef] [PubMed].
    [Google Scholar]
  13. Richt J.A., García-Sastre A.. ( 2009;). Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333: 177–195 [PubMed].
    [Google Scholar]
  14. Soubies S.M., Volmer C., Guérin J.L., Volmer R.. ( 2010;). Truncation of the NS1 protein converts a low pathogenic avian influenza virus into a strong interferon inducer in duck cells. Avian Dis 54: (Suppl), 527–531 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000171
Loading
/content/journal/jgv/10.1099/vir.0.000171
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error